Oxidized cardiolipin as a novel proinflammatory factor

Details for Australian Patent Application No. 2009328507 (hide)

Owner Medirista Biotechnologies AB

Inventors Frostegard, Johan

Agent Shelston IP

Pub. Number AU-A-2009328507

PCT Pub. Number WO2010/069605

Priority 61/138,966 19.12.08 US

Filing date 21 December 2009

Wipo publication date 24 June 2010

International Classifications

G01N 33/564 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for pre-existing immune complex or autoimmune disease

A61K 31/00 (2006.01)

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

14 July 2011 PCT application entered the National Phase

  PCT publication WO2010/069605 Priority application(s): WO2010/069605

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009328509-Method for blocking subterranean formations

2009328505-Human anti-alpha-synuclein autoantibodies